December 20, 2018 / 2:34 PM / 7 months ago

BRIEF-Novartis - Endocyte Shareholders Approve Merger Agreement

Dec 20 (Reuters) - Novartis AG:

* ENDOCYTE STOCKHOLDERS APPROVE MERGER AGREEMENT WITH NOVARTIS AG

* NOVARTIS AG WILL ACQUIRE ENDOCYTE FOR $24 PER SHARE, OR A TOTAL EQUITY VALUE OF APPROXIMATELY $2.1 BILLION, IN CASH

* APPROXIMATELY 99.8% OF VOTES CAST AT MEETING VOTED TO APPROVE ADOPTION OF MERGER AGREEMENT, REPRESENTING APPROXIMATELY 69.5% OF ENDOCYTE’S OUTSTANDING COMMON STOCK

* SUBJECT TO SATISFACTION OF CUSTOMARY CLOSING CONDITIONS, PROPOSED MERGER IS EXPECTED TO CLOSE ON OR ABOUT DECEMBER 21, 2018 Source text for Eikon: Further company coverage: (Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below